Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer

NCT03490292 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Resectable Esophageal Cancer
GastroEsophageal Cancer

Interventions

COMBINATION_PRODUCT: Avelumab combined with Chemoradiation
DRUG: Carboplatin
DRUG: Paclitaxel
RADIATION: Radiation

Sponsor

University of Wisconsin, Madison